RHAMM expressed on the cell surface promotes the motile behaviour of progenitor thymocytes (CD3-CD4-CD8-) and malignant B cells from myeloma and leukaemia, while the soluble RHAMM impedes the locomotion of fibroblasts [256]. Here, HMMR is linked to leukemia.